WO2004026222A3 - Compositions which are used to care for skin suffering from a hormonal imbalance and which contain one or more resveratrol oligomers, particularly $g(e)-viniferin, and/or certain derivatives thereof - Google Patents

Compositions which are used to care for skin suffering from a hormonal imbalance and which contain one or more resveratrol oligomers, particularly $g(e)-viniferin, and/or certain derivatives thereof Download PDF

Info

Publication number
WO2004026222A3
WO2004026222A3 PCT/FR2003/002755 FR0302755W WO2004026222A3 WO 2004026222 A3 WO2004026222 A3 WO 2004026222A3 FR 0302755 W FR0302755 W FR 0302755W WO 2004026222 A3 WO2004026222 A3 WO 2004026222A3
Authority
WO
WIPO (PCT)
Prior art keywords
skin
hormonal
resveratrol
products
viniferin
Prior art date
Application number
PCT/FR2003/002755
Other languages
French (fr)
Other versions
WO2004026222A2 (en
Inventor
Alain Fructus
Original Assignee
Af Consulting
Alain Fructus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Af Consulting, Alain Fructus filed Critical Af Consulting
Priority to AU2003283474A priority Critical patent/AU2003283474A1/en
Publication of WO2004026222A2 publication Critical patent/WO2004026222A2/en
Publication of WO2004026222A3 publication Critical patent/WO2004026222A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/17—Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair

Abstract

The invention relates to compositions which are used to care for skin suffering from a hormonal imbalance and which contain one or more resveratrol oligomers, particularly ε-viniferin, and/or certain derivatives thereof. Hormonal imbalances have negative effects on the condition of the skin, nails, hair, lips, external genital organs, oral mucous membranes, and the menopause essentially causes relatively significant hormonal imbalances. Products containing those hormones which the skin lacks have been developed solely in the pharmaceutical field as said hormones are prohibited for use in cosmetics. Non-steroid phytohormones have also been used, but most research with said products has been carried out by means of oral treatment. There has been no very explicit research relating to topical treatments. Retinoids represent another category of molecules which are used to treat the cutaneous symptoms of hormonal imbalances but retinoid acid is prohibited in cosmetics as it is teratogenic and extremely irritant. However, research has been carried out, and patents issued, relating to products based on a stilbene, namely Resveratrol. A test performed on the skin of post-menopausal women, non-substituted, shows that ε-viniferin (a dimer of Resveratrol) and a vegetable extract containing same produce hormonal and retinoid effects on the deficient skin. This type of activity has never been described before. The invention relates to cosmetic products, pharmaceutical products and food supplements which are intended to prevent and combat the negative effects caused by a hormonal imbalance affecting the skin and the appendages thereof. The inventive compositions contain at least one Resveratrol oligomer and/or one derivative and/or one vegetable extract containing same.
PCT/FR2003/002755 2002-09-20 2003-09-19 Compositions which are used to care for skin suffering from a hormonal imbalance and which contain one or more resveratrol oligomers, particularly $g(e)-viniferin, and/or certain derivatives thereof WO2004026222A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003283474A AU2003283474A1 (en) 2002-09-20 2003-09-19 Compositions which are used to care for skin suffering from a hormonal imbalance and which contain one or more resveratrol oligomers, particularly $g(e)-viniferin, and/or certain derivatives thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0211628 2002-09-20
FR0211628A FR2844714B1 (en) 2002-09-20 2002-09-20 COMPOSITIONS FOR SKIN CARE UNDER HORMONAL IMBALANCE, AND CONTAINING RESVERATROL OLIGOMERS, ESPECIALLY EPSILONE VINIFERIN, AND / OR SOME OF THEIR DERIVATIVES

Publications (2)

Publication Number Publication Date
WO2004026222A2 WO2004026222A2 (en) 2004-04-01
WO2004026222A3 true WO2004026222A3 (en) 2004-06-03

Family

ID=31970824

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2003/002755 WO2004026222A2 (en) 2002-09-20 2003-09-19 Compositions which are used to care for skin suffering from a hormonal imbalance and which contain one or more resveratrol oligomers, particularly $g(e)-viniferin, and/or certain derivatives thereof

Country Status (3)

Country Link
AU (1) AU2003283474A1 (en)
FR (1) FR2844714B1 (en)
WO (1) WO2004026222A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109769802B (en) * 2019-03-22 2021-11-30 吉林农业大学 Cryopreservation method and thawing method of vitis amurensis stem section and thawed vitis amurensis stem section

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7322928B2 (en) 2003-03-17 2008-01-29 Medi-Physics, Inc. Products and methods for brachytherapy
FR2862533B1 (en) * 2003-11-21 2006-04-28 Oreal COSMETIC USE OF AT LEAST ONE ACTIVATOR IN THE PRODUCTION OF AN INTERLEUKIN 11 AS A TOPICAL SLIMMING AGENT
FR2867977B1 (en) * 2004-03-26 2013-04-12 Af Consulting COMPOSITIONS FOR LIMITING THE WRINKLES OF THE SKIN CAUSED BY SUBCUTANEOUS MUSCLE CONTRACTIONS AND CONTAINING RESVERATROL AND / OR DERIVATIVES THEREOF
US20070048246A1 (en) 2005-09-01 2007-03-01 Biophysica Research, Inc. Novel skin care compositions
FR2898493B1 (en) * 2006-03-16 2008-08-08 Af Consulting COSMETIC, PHARMACEUTICAL, FOOD AND VETERINARY COMPOSITIONS WHOSE ACTION ACTIVATION OF SIRTUIN GENES ENABLES DELAYING THE AGING OF MAMMALS AND ITS NEGATIVE EFFECTS
JP2011105624A (en) * 2009-11-13 2011-06-02 Nof Corp Epidermal keratinocyte-activating agent and external preparation for skin
JP5967858B2 (en) * 2009-11-13 2016-08-10 日油株式会社 Hyaluronidase activity inhibitor
CN102432620B (en) * 2011-09-09 2013-12-04 南京大学 Resveratrol tetramer compound, its preparation method and application
CN103070849B (en) * 2013-01-29 2014-06-04 江苏省中国科学院植物研究所 Application of oxyresveratrol in preparing ovary aging resistant medicine
FR3003758B1 (en) * 2013-03-27 2015-07-17 Basf Beauty Care Solutions France Sas COSMETIC OR DERMATOLOGICAL USE OF A POLYGONUM BISTORTA EXTRACT
JP5859587B2 (en) * 2014-03-03 2016-02-10 日油株式会社 Topical skin preparation
US10456343B2 (en) 2017-01-26 2019-10-29 L'oreal Microemulsion compositions comprising polydatin and method of use
CN109810084B (en) * 2019-03-02 2022-04-19 中国科学院昆明植物研究所 Paeonilactiflorol, pharmaceutical composition thereof, preparation method and application thereof

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0892053A (en) * 1994-09-20 1996-04-09 Tsuneo Nanba External preparation for skin
FR2766176A1 (en) * 1997-07-15 1999-01-22 Caudalie COMPOSITIONS BASED ON RESVERATROL DERIVATIVES
JP2000136131A (en) * 1998-08-26 2000-05-16 Fukuoka Prefecture 5alpha-reductase inhibitor
EP1013260A2 (en) * 1998-12-22 2000-06-28 L'oreal Use of hydroxystilbenes for dyeing, ready-to-use composition containing them and dyeing process
FR2790645A1 (en) * 1999-03-12 2000-09-15 Arkopharma Laboratoires FOOD SUPPLEMENT AND COSMETIC PROCESSING METHOD BASED ON GRAPE EXTRACT RICH IN POLYPHENOLS
JP2000256154A (en) * 1999-03-12 2000-09-19 Sunstar Inc Pharmaceutical composition, oral composition, and food and drink composition, for treating or prophylactic disease accompanying degeneracy of gingival connective tissue or decrease of alveolar bone
EP1064931A1 (en) * 1999-07-02 2001-01-03 L'oreal Cosmetic composition containing at least an hydroxystilbene and ascorbic acid
US6319523B1 (en) * 2000-06-29 2001-11-20 James H. Zhou Composition and method for inhibiting oral bacteria
WO2001091695A2 (en) * 2000-06-02 2001-12-06 D.B.P. Di Rossi Valentina E C. S.N.C. The use of resveratrol as sunscreen
EP1175888A2 (en) * 2000-07-28 2002-01-30 L'oreal Topical compositions comprising glycosylated hydroxystilbenes and their uses
FR2816843A1 (en) * 2000-11-23 2002-05-24 Actichem 5-Alpha reductase inhibitor used for treating disorders due to excess dihydrotestosterone e.g. acne and alopecia comprise cis or trans resveratrol and its derivatives

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0892053A (en) * 1994-09-20 1996-04-09 Tsuneo Nanba External preparation for skin
FR2766176A1 (en) * 1997-07-15 1999-01-22 Caudalie COMPOSITIONS BASED ON RESVERATROL DERIVATIVES
JP2000136131A (en) * 1998-08-26 2000-05-16 Fukuoka Prefecture 5alpha-reductase inhibitor
EP1013260A2 (en) * 1998-12-22 2000-06-28 L'oreal Use of hydroxystilbenes for dyeing, ready-to-use composition containing them and dyeing process
FR2790645A1 (en) * 1999-03-12 2000-09-15 Arkopharma Laboratoires FOOD SUPPLEMENT AND COSMETIC PROCESSING METHOD BASED ON GRAPE EXTRACT RICH IN POLYPHENOLS
JP2000256154A (en) * 1999-03-12 2000-09-19 Sunstar Inc Pharmaceutical composition, oral composition, and food and drink composition, for treating or prophylactic disease accompanying degeneracy of gingival connective tissue or decrease of alveolar bone
EP1064931A1 (en) * 1999-07-02 2001-01-03 L'oreal Cosmetic composition containing at least an hydroxystilbene and ascorbic acid
WO2001091695A2 (en) * 2000-06-02 2001-12-06 D.B.P. Di Rossi Valentina E C. S.N.C. The use of resveratrol as sunscreen
US6319523B1 (en) * 2000-06-29 2001-11-20 James H. Zhou Composition and method for inhibiting oral bacteria
EP1175888A2 (en) * 2000-07-28 2002-01-30 L'oreal Topical compositions comprising glycosylated hydroxystilbenes and their uses
FR2816843A1 (en) * 2000-11-23 2002-05-24 Actichem 5-Alpha reductase inhibitor used for treating disorders due to excess dihydrotestosterone e.g. acne and alopecia comprise cis or trans resveratrol and its derivatives

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; XP002244636, Database accession no. 2000:316933 *
DATABASE WPI Week 199624, Derwent World Patents Index; AN 1996-235933, XP002244637 *
KE-XU YAN ET AL.: "A novel oligostilbene named (+)-viniferol A", TETRAHEDRON, vol. 57, no. 14, 2 April 2001 (2001-04-02), pages 2711 - 2715, XP004232230 *
PATENT ABSTRACTS OF JAPAN vol. 2000, no. 12 3 January 2001 (2001-01-03) *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109769802B (en) * 2019-03-22 2021-11-30 吉林农业大学 Cryopreservation method and thawing method of vitis amurensis stem section and thawed vitis amurensis stem section

Also Published As

Publication number Publication date
AU2003283474A8 (en) 2004-04-08
FR2844714B1 (en) 2007-04-27
FR2844714A1 (en) 2004-03-26
WO2004026222A2 (en) 2004-04-01
AU2003283474A1 (en) 2004-04-08

Similar Documents

Publication Publication Date Title
WO2004026222A3 (en) Compositions which are used to care for skin suffering from a hormonal imbalance and which contain one or more resveratrol oligomers, particularly $g(e)-viniferin, and/or certain derivatives thereof
AR013225A1 (en) METHODS AND COMPOSITIONS AGAINST FINE LINES AND / OR WRINKLES
RU2004131193A (en) TREATMENT OF DISEASES ASSOCIATED WITH DEFECTIVE COMMUNICATION THROUGH CRACKED CONTACTS
JP5284093B2 (en) Anti-inflammatory compositions and methods of use
JP6530362B2 (en) Skin cosmetics
AU2006285299B2 (en) Anti-inflammatory compositions and methods of use
KR900017590A (en) Acne treatment method and pharmaceutical composition thereof
KR960000855A (en) L-carnitine salt and cosmetic composition and pharmaceutical composition for treating skin disease containing same
GB2476324A (en) Low toxicity topical active agent delivery system
KR960010002A (en) L-carnitine salt and cosmetic composition and pharmaceutical composition for treating skin disease containing same
Bellad et al. Development ofcosmeceuticals
EP3090781A1 (en) Anti-age composition with plant extracts
US7186685B2 (en) Compositions comprising gelatin-glycine and carotenoids
HUP0304077A2 (en) Pharmaceutical and cosmetic compositions against skin aging
Rona et al. Aging skin and food supplements: the myth and the truth
KR960010003A (en) L-carnitine salt and cosmetic composition and pharmaceutical composition for treating skin disease containing same
BRPI0410251A (en) melanogenesis promoter, and, melanogenesis promoter composition
JPS59216812A (en) Hair restoring agent
BR9810072A (en) Semi-solid pharmaceutical formulation containing dexcetoprofen trometamol
US9682025B2 (en) Combination of active agents for oral administration for improving the quality of nails
JP2010047535A (en) Skin external preparation
Ambhore et al. Comparative evaluation of the efficacy of Triphala gel and chlorhexidine digluconate gel in management of patients with chronic gingivitis: A randomized clinical trial
CA2428902A1 (en) Compositions having comfrey and methods for reducing retinoid-induced skin irritation
Goossens Contact Dermatitis Due to Cosmetics
Somwanshi et al. Cosmetic Science

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP